SCHEMBL5146685

SCHEMBL5146685

CC1(C)C(=O)Nc2cc3[nH]c(-c4c(I)cc[nH]c4=O)nc3cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.53
PDE3A Q14432 3/20 0.53
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
PDE4D Q08499 2/20 0.53
AURKA O14965 2/20 0.49
AURKB Q96GD4 2/20 0.49
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
ERAP1 Q9NZ08 1/20 0.38
JAK1 P23458 7/20 0.34
JAK2 O60674 3/20 0.34
TYK2 P29597 2/20 0.34
JAK3 P52333 2/20 0.34
PRKAA1 Q13131 2/20 0.34
NUAK1 O60285 1/20 0.34
PDGFRA P16234 1/20 0.34
FLT3 P36888 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5131647 0.87 PDE3B (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL5132785 0.79 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL5131983 0.77 AURKA (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10569087 0.77 PDE3B (0.57) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10373374 0.75 PDE3B (0.68) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10375588 0.75 PDE4A (0.71) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10568694 0.74 AURKA (0.62) PDE3BPDE3APDE4APDE4BPDE4C
Adibendan SCHEMBL9832050 0.74 PDE3B (0.90) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10374221 0.73 PDE4A (0.68) PDE3BPDE3APDE4APDE4BPDE4C
Adibendan SCHEMBL10470994 0.73 PDE3B (0.88) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008022747-A1 TRICYCLIC LACTAM DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-02-28 WO disclosed